Product Information
- CB 7598
- (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol
- 17-(3-Pyridinyl)-androsta-5,16-dien-3beta-ol
- (3Beta)-17-(Pyridin-3-Yl)Androsta-5,16-Dien-3-Ol
- (3b)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol
- 17-(3-Pyridinyl)-androsta-5,16-dien-3β-ol
- 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
- Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3β)-
- Cb 7598
Applications Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
References Denis, L., et al.: Cancer, 72, 3888 (1993); Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995); Denmeade, S., et al.: Nat. Rev., 2, 389 (2002); Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005);
Chemical properties
Technical inquiry about: TR-A108490 Abiraterone
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.